111333 ⎘
ssRNA viruses positive-sense; Details; Flaviviridae Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
Sub-classes:Method for Producing Virus-Infected Cell Line and Animal Model
#2Repressors of viral infection
#3COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS
#4COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS
#5METHODS AND DEVICES FOR DETECTING HEPATITIS C VIRUS
#6Peptide and its derivatives capable of inhibiting replication of hepatitis V virus in human adipose-derived stem cells and hepatocytes
#7Viral RNA segments as immunomodulatory agents and vaccine components
#8Methods for inhibiting HIV or HCV infection by administering TIM-3 binding inhibitors
#9Methods and compositions for reducing viral genome amounts in a target cell
#10Vaccination with immuno-isolated cells producing an immunomodulator
#11Treating hepatitis C virus infection
#12Methods and cells for identifying RIG-I pathway regulators
#13T cell receptors specific for immunodominant CTL epitopes of HCV
#14Methods and compositions for reducing viral genome amounts in a target cell
#15COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS
#16Replication stable and RNase resistant chimeras of with insertion in 3′ nontranslated region (3′NTR)
#17INHIBITION OF VIRAL GENE EXPRESSION USING SMALL INTERFERING RNA
#18Methods and compositions of treating a family viral infection
#19HCV-derived polypeptides and uses thereof
#20RNAi expression constructs
#21Recognition of CYP2E1 epitopes
#22Chimeric pestivirus with insertion in 3′ nontranslated region (3′NTR) with stable replication and rnase resistance
#23Hepatitis C virus inhibitors
#24HCV entry factor, Occludin
#25Inhibition of viral gene expression using small interfering RNA
#26Isoflavone anti-viral compounds
#27Hepatitis C virus inhibitors
#28Host cell kinases as targets for antiviral therapies against HCV infection
#29ANALYTICAL METHOD FOR THE DETECTION OF LATENT HEPATITIS C, USE THEREOF AND CORRESPONDING DIAGNOSIS KIT
#30Methods and compositions for reducing viral genome amounts in a target cell
#31ADAPTABLE MODIFIED VIRUS VECTOR TO DELIVER RIBOSOMAL RIBONUCLEIC ACID COMBINED WITH MESSENGER RIBONUCLEIC ACID AS A MEDICAL TREATMENT DEVICE TO MANAGE DIABETES MELLITUS AND OTHER PROTEIN DEFICIENT DIEASES
#32Hepatitis C virus inhibitors
#33Hepatitis C virus inhibitors
#34Hepatitis C virus inhibitors
#35Hepatitis C virus inhibitors
#36Hepatitis C virus inhibitors
#37ANTI-HEPATITIS C ACTIVITY OF MESO-TETRAKIS-PORPHYRIN ANALOGUES
#38MicroRNAs for inhibiting viral replication
#39Methods of inhibiting viral replication and improving T cell function employing soluble Tim-3 inhibitors
#40Compounds for immunopotentiation
#41Linked diimidazole antivirals
#42Linked dibenzimidazole derivatives
#43ORGANIC COMPOUNDS AND THEIR USES
#44Treating Hepatitis C Virus Infection
#45Methods and reagents for genotyping HCV
#46METHODS, USES AND COMPOSITIONS FOR MODULATING REPLICATION OF HCV THROUGH THE FARNESOID X RECEPTOR (FXR) ACTIVATION OR INHIBITION
#47Replication Stable and RNase Resistant Chimeras of Pestivirus with Insertion in 3' Nontranslated Region (3'NTR)
#48COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS
#49COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE TO ESCAPE MUTANTS OF TARGETED THERAPIES
#50RNAi expression constructs
#51Biodegradable Cross-Linked Branched Poly(Alkylene Imines)
#52RNA interference mediated inhibition of hepatitis C virus (HCV) expression using short interfering nucleic acid (siNA)
#53Isolation of Inhibitors of IRES-Mediated Translation
#54HEPATITIS C ANTIVIRALS
#55Agents and methods based on the use of the EDA domain of fibronectin
#56HEPATITIS C ANTIVIRALS
#57Small interfering rnas that efficiently inhibit viral expression and methods of use thereof
#58COMPOSITIONS AND METHODS TO INHIBIT RNA VIRAL REPRODUCTION
#59Pharmaceutical compositions for and methods of inhibiting HCV replication
#60Pyrrolidine Derivatives
#61Methods and compositions for reducing viral genome amounts in a target cell
#62Pharmaceutical Compositions For and Methods of Inhibiting Hcv
#63RNA inteference mediated inhibition of hepatitis C virus (HVC) gene expression using short interfering nucleic acid (siNA)
#64Treating hepatitis C virus infection
#65Vaccination with immuno-isolated cells producing an immunomodulator
#66Bacterial Packaging Strains Useful for Generation and Production of Recombinant Double-Stranded RNA Nucleocapsids and Uses Thereof
#67Compositions and methods for the modulation of detrusor activity
#68METHODS AND REAGENTS FOR GENOTYPING HCV
#69Inhibition of viral gene expression using small interfering RNA
#70Quantitative assay for detection of newly synthesized RNA in a cell-free system and identification of RNA synthesis inhibitors
#71Drug-resistant mutants of hepatitis C virus
#72Methods of identifying optimal variants of peptide epitopes
#73RNAi expression constructs
#74FBL2-specific agents as modulators of Flaviviridae RNA replication
#75RNA inteference mediated inhibition of hepatitis C virus (HVC) gene expression using short interfering nucleic acid (siNA)
#76Dose forms
#77Vaccination with immuno-isolated cells producing an immunomodulator
#78Methods and compositions for reducing viral genome amounts in a target cell
#79Microparticles with adsorbent surfaces, methods of making same, and uses thereof
#80Microparticles with adsorbent surfaces, methods of making same, and uses thereof